Are Iranian patients with von Willebrand disease type 2N properly differentiated from hemophilia A and do they receive appropriate treatment?
This study also emphasized the need for inclusion of the VWF:FVIIIB in suspected hemophilia A to achieve an optimal treatment strategy.
Source: Blood Coagulation and Fibrinolysis - Category: Hematology Tags: ORIGINAL ARTICLES Source Type: research
More News: Bleeding | Blood Transusion | Genetics | Haemophilia | Hematology | Hemophilia | Iran Health | Laboratory Medicine | Middle East Health | Study | Thrombosis | von Willebrand Disease